Biomaterial Database

Reduced 2',3'-cyclic nucleotide 3'-phosphohydrolase activity in erythrocyte membranes of patients with multiple sclerosis. 1985

C E Dreiling, and C Norrgran, and E Smith

Division of Biochemistry, School of Medicine, University of Nevada, Reno 89557.

2',3'-Cyclic nucleotide 3'-phosphohydrolase (CNPase) activity is reduced in myelin during multiple sclerosis. Therefore, we have investigated whether the enzyme is also depressed in non-neural membranes during this disease. MS and control erythrocyte membranes and whole lymphocytes were assayed for CNPase activity. The MS erythrocyte membrane preparations were found to exhibit up to 45% lower CNPase levels than the controls (P less than 0.02). There was no significant difference in the lymphocyte CNPase levels in MS and control groups. When control erythrocyte membrane preparations were assayed in the presence of MS plasma they were inhibited 100% by MS (but not by control) plasma. These data suggest that erythrocyte membrane CNPase activity is significantly reduced in MS patients and that the reduction in activity may be due to an inhibitor present in MS plasma.

UI	MeSH Term	Description	Entries
D008214	Lymphocytes	White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS.	Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009103	Multiple Sclerosis	An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)	MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D012016	Reference Values	The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.	Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004910	Erythrocyte Membrane	The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS.	Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D015087	2',3'-Cyclic-Nucleotide Phosphodiesterases	Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-.	2',3'-Cyclic Nucleotide Phosphodiesterase,2',3'-Cyclic Nucleotide Phosphodiesterases,2,3-Cyclic Nucleotide Phosphodiesterase,2,3-Cyclic Nucleotide Phosphodiesterases,CNPase,2',3' Cyclic Nucleotide Phosphodiesterase,2',3' Cyclic Nucleotide Phosphodiesterases,2,3 Cyclic Nucleotide Phosphodiesterase,2,3 Cyclic Nucleotide Phosphodiesterases,Nucleotide Phosphodiesterase, 2',3'-Cyclic,Nucleotide Phosphodiesterase, 2,3-Cyclic,Nucleotide Phosphodiesterases, 2',3'-Cyclic,Nucleotide Phosphodiesterases, 2,3-Cyclic,Phosphodiesterase, 2',3'-Cyclic Nucleotide,Phosphodiesterase, 2,3-Cyclic Nucleotide,Phosphodiesterases, 2',3'-Cyclic Nucleotide,Phosphodiesterases, 2',3'-Cyclic-Nucleotide,Phosphodiesterases, 2,3-Cyclic Nucleotide